Edward Mitre is a co-inventor of the platform and a Professor in the Department of Microbiology and Immunology at the Uniformed Services University (USU) in Bethesda, Maryland. Dr. Mitre obtained his medical degree from the Johns Hopkins School of Medicine in 1995 and then completed his internal medicine residency at New York University, where he served as the senior chief resident from 1998-1999. He completed an infectious diseases fellowship at the National Institutes of Health from 1999-2002, followed by post-doctoral research work in helminth immunology as well as clinical training in tropical medicine at the Laboratory of Parasitic Diseases at NIH. He teaches a variety of classes in parasitology, mycology, and bacteriology at the USU medical school, and he co-directs graduate courses in Molecular Parasitology and Emerging Infectious Diseases. Current studies in Dr. Mitre’s laboratory are focused on identifying novel drug and vaccine targets in filarial nematodes, evaluating natural products for the treatment of filariae, developing helminth-derived therapies for allergy and autoimmunity, and elucidating the mechanisms that drive immunoregulation in chronic helminth infections and allergy immunotherapy. Additionally, Dr. Mitre is the primary investigator of the Prospective Assessment of SARS-CoV-2 Seroconversion study, a prospective study assessing how baseline immune factors affect clinical and immunological outcomes to COVID-19 infection and vaccination. In addition to his research and teaching responsibilities at USU, Dr. Mitre is a member of the Infectious Diseases Division at Walter Reed National Military Medical center, where he regularly attends on the internal medicine and infectious diseases services.